Edition:
United Kingdom

SINOPHARM GROUP CO LTD (1099.HK)

1099.HK on Hong Kong Stock

33.70HKD
2:53am BST
Change (% chg)

HK$0.65 (+1.97%)
Prev Close
HK$33.05
Open
HK$33.05
Day's High
HK$33.90
Day's Low
HK$33.05
Volume
926,438
Avg. Vol
6,909,363
52-wk High
HK$45.65
52-wk Low
HK$29.85

Chart for

About

Sinopharm Group Company Limited is principally engaged in the distribution of pharmaceutical products and medical equipment. The Company operates through three business segments. The Pharmaceutical Distribution segment is engaged in the distribution of medicines, medicine devices and pharmaceutical products to hospitals, other... (more)

Overall

Beta: 0.92
Market Cap(Mil.): HK$97,540.10
Shares Outstanding(Mil.): 2,767.09
Dividend: 0.57
Yield (%): 1.62

Financials

  1099.HK Industry Sector
P/E (TTM): 17.00 20.98 40.93
EPS (TTM): 2.07 -- --
ROI: 16.68 11.72 62.12
ROE: 15.21 13.91 73.69

BRIEF-Sinopharm Group Posts Qtrly Net Profit Attributable RMB842.7 Million

* QTRLY TOTAL OPERATING REVENUE RMB72.69 BILLION VERSUS RMB68.42 BILLION

12:11am BST

BRIEF-Sinopharm Group Co Expects Q1 Net Profit Attributable Down About 30%

* EXPECTS Q1 NET PROFIT ATTRIBUTABLE TO RECORD DECLINE OF ABOUT 30%

10 Apr 2018

BRIEF-Sinopharm Group Co Posts ‍FY Profit Of RMB5.28 Bln

* ‍FY PROFIT ATTRIBUTABLE RMB 5.28 BILLION VERSUS RMB 4.65 BILLION ​ Source text for Eikon: Further company coverage:

25 Mar 2018

BRIEF-Sinopharm Group Co's Board Resolves To Propose Issue Of Corporate Bonds In China

* BOARD RESOLVED TO PROPOSE ISSUE OF CORPORATE BONDS IN PRC; ISSUE SIZE OF NO MORE THAN RMB10 BILLION Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

12 Jan 2018

BRIEF-Sinopharm Group posts ‍9-mnth profit attributable of RMB ‍3.66​ billion​

* 9-month net profit attributable to equity holders of co RMB ‍3.66​ billion versus RMB3.60 billion

30 Oct 2017

Earnings vs. Estimates